Updated time: 2024-10-09 17:05:46
28A-1051024
TW I725253 I852306、JP 6975233、IN 400182、KR 10-2439864、10-2654566、US 11,480,391 B2、TW I 793547、KR 10-2527547、CA 3042447、CN ZL 201780068958.6、US 12,085,340 B2
Using IAV without the stalk and catalytic domains of NA as live attenuated vaccine was shown to confer a strong IAV-specific CD8+ T-cell response and a strong cross-strain as well as cross-subtype protection against various virus strains. Therefore, our findings prove a new technology and principle to develop influenza vaccine.
Recent development of universal influenza vaccines is focused on the use of conserved peptides or proteins as antigens with different adjuvants and administration methods to induce immune response (1-4). Expression of the conserved regions of IAV proteins by using viral vector systems can induce CD8+ T cells against lethal IAV challenge in animals, but it still only recognizes one target (5). Another type of vaccine based on the mixture of MVA-NP and M1 was also reported (6). In this study, the IAV without the stalk and catalytic domains of NA (without NA activity) was found to significantly induce IAV-specific CD8+ T cells that recognize various strains and different subtypes of IAV in the absence of neutralizing antibodies. While it is known that human IAV-specific CD8+ T cells provide cross-protection against influenza (7), In addition, our finding prove the first nasal spray universal influenza vaccine in the world.
- Lee YN, et al. (2016) A Novel Vaccination Strategy Mediating the Induction of Lung-Resident Memory CD8 T Cells Confers Heterosubtypic Immunity against Future Pandemic Influenza Virus. J Immunol, 196(6) : 2637-2645.
- Nachbagauer R, et al. (2016) Age Dependence and Isotype Specificity of Influenza Virus Hemagglutinin Stalk-Reactive Antibodies in Humans. MBio, 7(1): pii: e01996-15.
- He B, et al. (2015) Adenovirus-based vaccines against avian-origin H5N1 influenza viruses. Microbes Infect, 17(2):135-141.
- van de Sandt CE, et al. (2015) Differential Recognition of Influenza A Viruses by M158-66 Epitope-Specific CD8+ T Cells Is Determined by Extraepitopic Amino Acid Residues. J Virol. 90(2):1009-1022.
- He F, et al. (2016) Strategies towards universal pandemic influenza vaccines. Expert Rev Vaccines. 15(2)::215-225.
- Berthoul TK, et al. (2011) Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1. Clin Infect Dis 52(1):1-7.
- Saranya Sridhar, et al. (2013) Cellular immune correlates of protection against symptomatic pandemic influenza. Nat Med. 19(10):1305-1312.
Our technology and principle can help human to develop a new generation of universal influenza vaccine.
Chi-Huey Wong、Chung-Yi Wu
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Request for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office

Nasal spray universal influenza vaccine